General AML

ESH 2019 | How do you integrate molecular diagnostics in clinical practice?

L:

The AML Global Portal were delighted to speak to Peter Valk, Erasmus University Medical Center, Rotterdam, NL, during the European School of Hematology (ESH) Translational Research Conference on AML. We asked Peter Valk: How do you integrate molecular diagnostics in clinical practice?

Peter Valk discusses the role of Next Generation Sequencing (NGS) in clinical decision- making in AML. He explains the important role of NGS in routine molecular-based diagnostics, prognostic and response monitoring such as measuring the presence or absence of whole genes and monitoring somatic and germline mutations.

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF
Was this article informative? Thank you for your feedback!
100% of people found this article informative